- Report
- May 2024
- 137 Pages
Global
From €6456EUR$6,499USD£5,368GBP
- Report
- May 2024
- 137 Pages
Global
From €6456EUR$6,499USD£5,368GBP
- Report
- May 2024
- 130 Pages
Global
From €6456EUR$6,499USD£5,368GBP
- Report
- May 2024
- 130 Pages
Global
From €6456EUR$6,499USD£5,368GBP
- Report
- May 2024
- 134 Pages
Global
From €6456EUR$6,499USD£5,368GBP
- Report
- April 2024
- 135 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- April 2024
- 136 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- April 2024
- 137 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- January 2024
- 141 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- June 2024
- 185 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- February 2024
- 110 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 115 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 160 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 128 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 120 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 120 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Clinical Trials
- June 2024
- 80 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Clinical Trials
- April 2024
- 115 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Report
- January 2024
- 120 Pages
Global
From €5529EUR$5,565USD£4,597GBP
€7898EUR$7,950USD£6,567GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more